These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14509056)

  • 1. [Neuroleptic therapy of comorbid narcotic dependent patients in ambulatory methadone maintenance].
    Unglaub W; Kandel M; Zenner D; Wodarz N; Klein H
    Psychiatr Prax; 2003 May; 30 Suppl 2():S121-4. PubMed ID: 14509056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic Treatment of Opiate Addicts with a Comorbid Schizophrenia in a Methadone Maintenance Program].
    Unglaub W; Kandel M; Zenner D; Wodarz N; Klein H
    Psychiatr Prax; 2003 May; 30(Suppl 2):121-124. PubMed ID: 13130354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
    Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome of a substitution therapy program in an outpatient treatment setting of a psychiatric hospital].
    Unglaub W; Loncarek E; Wismath M; Johann M; Wodarz N; Klein H
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S26-8. PubMed ID: 15570492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
    Carreño JE; Alvarez CE; Narciso GI; Bascarán MT; Díaz M; Bobes J
    Addict Biol; 2003 Dec; 8(4):429-38. PubMed ID: 14690879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
    Kim JH; Kim D; Marder SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inpatient withdrawal treatment of heroin dependence with neuroleptics--an approach to addicts].
    Presslich O; Schanda H; Hermann P
    Psychiatr Prax; 1983 Mar; 10(2):60-3. PubMed ID: 6134297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The experiences of the Munich methadone outpatient clinics].
    Meissner A; Burkhardt D; Donath E; Tretter F
    Psychiatr Prax; 1997 Nov; 24(6):291-5. PubMed ID: 9490444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
    Maremmani I; Pacini M; Lubrano S; Perugi G; Tagliamonte A; Pani PP; Gerra G; Shinderman M
    Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory medical treatment of drug dependent patients].
    Gölz J
    Z Arztl Fortbild (Jena); 1996 Jun; 90(4):271-8. PubMed ID: 8928526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The risk of rehospitalisation during therapy with atypical and typical neuroleptics--a contribution to differential indication].
    Müller P; Nerenz H; Schaefer E
    Psychiatr Prax; 2002 Oct; 29(7):388-91. PubMed ID: 12378421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.